Sanofi-Aventis Allergy Drug Approved for Pediatric Use
Posted on: Thursday, 19 October 2006, 12:00 CDT
The FDA has approved a liquid form of Sanofi-Aventis' allergy drug Allegra for the treatment of allergies in children.
The approval was for treatment of seasonal allergies and provides a treatment option that is non-impairing to pediatric populations as young as two years old.
"Until now, parents had few seasonal antihistamine treatment options that were not associated with cognitively impairing adverse side effects," says Eli Meltzer, of the Allergy and Asthma Medical Group and Research Center.
Seasonal allergic rhinitis is a common chronic condition in children. Symptoms of seasonal allergies include nasal drainage, sneezing, watery eyes and itchy nose, eyes and throat.
Allegra has also been approved for the treatment of chronic idiopathic urticaria (CIU) for pediatric patients. CIU is a rare condition characterized by hives and has an unknown cause.
Allegra is expected to be available to consumers in time for the 2007 spring allergy season.
Source: Datamonitor
Related Articles
- Milk Is Safe For Some Children After Treatment For Milk Allergy
- Studies Show Children Can Complete Treatment For Peanut Allergies And Achieve Long-Term Tolerance
- Treatment for peanut allergy tested
- New Food Allergy Treatment In The Works
- Survival Guide for Allergy Sufferers
- Alcon's PATANASE(R) Nasal Spray Approved By FDA for Treatment of Nasal Allergy Symptoms
- Allergy Drug Allegra Cleared for Kids
- Cobalis Corp. Phase III Trial for PreHistin(TM) Shows Positive Results for Pre-Seasonal Treatment to Mitigate Allergy Symptoms in Humans
- Treatment for Peanut Allergies Developed
 |
 |
User Comments (0)
RSS Feeds